Status:
ACTIVE_NOT_RECRUITING
I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cervical Carcinoma
Human Papillomavirus-Related Malignant Neoplasm
Eligibility:
All Genders
11+ years
Phase:
NA
Brief Summary
This trial studies how well a multi-level health system-based intervention works in improving human papillomavirus (HPV) vaccine initiation and completion among children in health systems in four Appa...
Detailed Description
PRIMARY OBJECTIVE: I. Test the effectiveness of a multi-level intervention (MLI) directed at clinics, providers, and patients (parents of children aged 11-12) to improve HPV vaccine initiation and co...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- CLINIC
- Located in one of the counties that are part of this program
- Provides care to patients aged 11-26
- Provides immunizations
- HEALTH CARE PROVIDERS (PHYSICIANS, NURSES) AND OFFICE STAFF
- Practicing in a clinic in one of the participating health systems
- Personnel involved in the vaccine process (determined by individual clinics)
- Able to speak, read, and write English
Exclusion
Key Trial Info
Start Date :
October 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2025
Estimated Enrollment :
372 Patients enrolled
Trial Details
Trial ID
NCT04452526
Start Date
October 21 2020
End Date
September 1 2025
Last Update
August 26 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky/Markey Cancer Center
Lexington, Kentucky, United States, 40536
2
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210
3
University of Virginia
Charlottesville, Virginia, United States, 22908
4
West Virginia University
Morgantown, West Virginia, United States, 26506